The Effect of Nusinersen Therapy on Laboratory Parameters of Patients with Spinal Muscular Atrophy
Gamze Sarıkaya Uzan(Izmir University), Uluç Yiş(Dokuz Eylül University), Özlem Özsoy(Dokuz Eylül University), Çağatay Günay(Dokuz Eylül University), Semra Hız Kurul(Dokuz Eylül University), Cem Paketçi(Dokuz Eylül University), Pınar Edem(Dokuz Eylül University)
Cited by 9
Related Papers
Clinico‐Genetic, Imaging and Molecular Delineation of <scp><i>COQ8A</i></scp>‐Ataxia: A Multicenter Study of 59 Patients
|Annals of Neurology|2020|77
Successful treatment of intractable epilepsy with ketogenic diet therapy in twins with ALG3-CDG
|Brain and Development|2020|16
Evaluation of the Patients with the Diagnosis of Pontocerebellar Hypoplasia: A Multicenter National Study
|The Cerebellum|2024|8
DPAGT1-CDG: Report of Two New Pediatric Patients and Brief Review of the Literature
|Molecular Syndromology|2023|6
Immunization status of patients with spinal muscular atrophy receiving nusinersen therapy
|Archives de Pédiatrie|2023|4